Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Cancer Immunology, Immunotherapy : CII
|
December 6, 2006
Vaccination with an adenoviral vector expressing calreticulin-human papillomavirus 16 E7 fusion protein eradicates E7 expressing established tumors in mice
Jorge G Gomez-Gutierrez, Kutlu G Elpek, Roberto Montes de Oca-Luna, et al.
Plos One
|
September 3, 2011
Lymphoid organ-resident dendritic cells exhibit unique transcriptional fingerprints based on subset and site
Kutlu G Elpek, Angelique Bellemare-Pelletier, Deepali Malhotra, et al.
Cancer Immunology Research
|
May 8, 2014
The tumor microenvironment shapes lineage, transcriptional, and functional diversity of infiltrating myeloid cells
Kutlu G Elpek, Viviana Cremasco, Hua Shen, et al.
Nature Immunology
|
September 20, 2011
Regulated release of nitric oxide by nonhematopoietic stroma controls expansion of the activated T cell pool in lymph nodes
Veronika Lukacs-Kornek, Deepali Malhotra, Anne L Fletcher, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 10, 2009
Intestinal tolerance is converted to autoimmune enteritis upon PD-1 ligand blockade
Erika D Reynoso, Kutlu G Elpek, Loise Francisco, et al.
Cancer Research
|
April 17, 2008
Interleukin-15/interleukin-15R alpha complexes promote destruction of established tumors by reviving tumor-resident CD8+ T cells
Mathieu Epardaud, Kutlu G Elpek, Mark P Rubinstein, et al.
Vaccine
|
October 20, 2009
A novel form of 4-1BBL has better immunomodulatory activity than an agonistic anti-4-1BB Ab without Ab-associated severe toxicity
Rich-Henry Schabowsky, Kutlu G Elpek, Shravan Madireddi, et al.
Cancer Research
|
April 22, 2010
4-1BB ligand as an effective multifunctional immunomodulator and antigen delivery vehicle for the development of therapeutic cancer vaccines
Rajesh K Sharma, Rich-Henry Schabowsky, Abhishek K Srivastava, et al.
Cell Reports
|
March 11, 2015
IgE/FcεRI-Mediated Antigen Cross-Presentation by Dendritic Cells Enhances Anti-Tumor Immune Responses
Barbara Platzer, Kutlu G Elpek, Viviana Cremasco, et al.
Nature Immunology
|
April 3, 2012
Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks
Deepali Malhotra, Anne L Fletcher, Jillian Astarita, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Cancer Immunology, Immunotherapy : CII
|
December 6, 2006
Vaccination with an adenoviral vector expressing calreticulin-human papillomavirus 16 E7 fusion protein eradicates E7 expressing established tumors in mice
Jorge G Gomez-Gutierrez, Kutlu G Elpek, Roberto Montes de Oca-Luna, et al.
Plos One
|
September 3, 2011
Lymphoid organ-resident dendritic cells exhibit unique transcriptional fingerprints based on subset and site
Kutlu G Elpek, Angelique Bellemare-Pelletier, Deepali Malhotra, et al.
Cancer Immunology Research
|
May 8, 2014
The tumor microenvironment shapes lineage, transcriptional, and functional diversity of infiltrating myeloid cells
Kutlu G Elpek, Viviana Cremasco, Hua Shen, et al.
Nature Immunology
|
September 20, 2011
Regulated release of nitric oxide by nonhematopoietic stroma controls expansion of the activated T cell pool in lymph nodes
Veronika Lukacs-Kornek, Deepali Malhotra, Anne L Fletcher, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 10, 2009
Intestinal tolerance is converted to autoimmune enteritis upon PD-1 ligand blockade
Erika D Reynoso, Kutlu G Elpek, Loise Francisco, et al.
Cancer Research
|
April 17, 2008
Interleukin-15/interleukin-15R alpha complexes promote destruction of established tumors by reviving tumor-resident CD8+ T cells
Mathieu Epardaud, Kutlu G Elpek, Mark P Rubinstein, et al.
Vaccine
|
October 20, 2009
A novel form of 4-1BBL has better immunomodulatory activity than an agonistic anti-4-1BB Ab without Ab-associated severe toxicity
Rich-Henry Schabowsky, Kutlu G Elpek, Shravan Madireddi, et al.
Cancer Research
|
April 22, 2010
4-1BB ligand as an effective multifunctional immunomodulator and antigen delivery vehicle for the development of therapeutic cancer vaccines
Rajesh K Sharma, Rich-Henry Schabowsky, Abhishek K Srivastava, et al.
Cell Reports
|
March 11, 2015
IgE/FcεRI-Mediated Antigen Cross-Presentation by Dendritic Cells Enhances Anti-Tumor Immune Responses
Barbara Platzer, Kutlu G Elpek, Viviana Cremasco, et al.
Nature Immunology
|
April 3, 2012
Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks
Deepali Malhotra, Anne L Fletcher, Jillian Astarita, et al.
Page
of 3